Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥175.2bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥62.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥208.2bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥154.2bn2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥56.5bn2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥58.7bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥22.4bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥84.6bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥22.7bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥60.2bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥22.2bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥96.2bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥85.2bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥22.9bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥39.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥15.2bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥63.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥56.2bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥15.4bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥41.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥15.9bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥58.5bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥15.8bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥380.7bnat 2022-12-31Cons.Assets IFRS
Total assets¥346.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥324.8bnat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥83.4bnat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥82.0bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥297.4bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥264.0bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥252.7bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥207.3bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥290.7bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥257.8bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥246.6bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥109.8bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥104.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥89.1bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥33.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥52.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥31.0bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥8.6bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥23.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥10.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥20.7bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥16.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥15.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥57.862022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥22.422022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥94.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥82.752021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥22.662021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥57.822022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.42022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥93.982021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥82.682021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.642021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio76.4%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.5%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio75.9%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 107
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥3.9bn
Reconciling Itemsreconcilingrevenue2022-10-01 → 2022-12-31−¥1.1bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥3.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2022-12-31−¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥418m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue2022-04-01 → 2022-12-31¥11.5bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue2022-10-01 → 2022-12-31¥3.1bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.8bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue external2022-10-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥623m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥178m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentsegment profit2022-04-01 → 2022-12-31¥4.2bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentsegment profit2022-10-01 → 2022-12-31¥734m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue2022-04-01 → 2022-12-31¥20.6bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue2022-10-01 → 2022-12-31¥6.6bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.1bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue external2022-10-01 → 2022-12-31¥6.4bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥521m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥174m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentsegment profit2022-04-01 → 2022-12-31¥6.0bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentsegment profit2022-10-01 → 2022-12-31¥1.8bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue2022-04-01 → 2022-12-31¥69.8bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue2022-10-01 → 2022-12-31¥27.2bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue external2022-04-01 → 2022-12-31¥67.4bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue external2022-10-01 → 2022-12-31¥26.5bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2.4bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥739m
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentsegment profit2022-04-01 → 2022-12-31¥32.1bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentsegment profit2022-10-01 → 2022-12-31¥13.3bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue2022-04-01 → 2022-12-31¥47.3bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue2022-10-01 → 2022-12-31¥17.1bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue external2022-04-01 → 2022-12-31¥47.2bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue external2022-10-01 → 2022-12-31¥17.1bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥21m
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥17m
jpcrp040300-q3r_E05425-000Overseasreportable segmentsegment profit2022-04-01 → 2022-12-31¥13.9bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentsegment profit2022-10-01 → 2022-12-31¥5.8bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue2022-04-01 → 2022-12-31¥27.5bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue2022-10-01 → 2022-12-31¥8.8bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue external2022-04-01 → 2022-12-31¥27.2bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue external2022-10-01 → 2022-12-31¥8.8bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥304m
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.2bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentsegment profit2022-10-01 → 2022-12-31¥917m
—segment totalrevenue2022-04-01 → 2022-12-31¥176.6bn
—segment totalrevenue2022-10-01 → 2022-12-31¥62.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥172.8bn
—segment totalrevenue external2022-10-01 → 2022-12-31¥61.6bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥3.8bn
—segment totalrevenue intersegment2022-10-01 → 2022-12-31¥1.1bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥59.5bn
—segment totalsegment profit2022-10-01 → 2022-12-31¥22.6bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥3.7bn
Reconciling Itemsreconcilingrevenue2021-10-01 → 2021-12-31−¥1.2bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥3.7bn
Reconciling Itemsreconcilingrevenue intersegment2021-10-01 → 2021-12-31−¥1.2bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥1.3bn
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2021-12-31−¥803m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue2021-04-01 → 2021-12-31¥11.0bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue2021-10-01 → 2021-12-31¥2.8bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue external2021-04-01 → 2021-12-31¥10.6bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue external2021-10-01 → 2021-12-31¥2.7bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥465m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentrevenue intersegment2021-10-01 → 2021-12-31¥102m
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentsegment profit2021-04-01 → 2021-12-31¥4.0bn
jpcrp040300-q3r_E05425-000Career Solutionreportable segmentsegment profit2021-10-01 → 2021-12-31¥582m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue2021-04-01 → 2021-12-31¥16.2bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue2021-10-01 → 2021-12-31¥6.1bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue external2021-04-01 → 2021-12-31¥15.5bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue external2021-10-01 → 2021-12-31¥5.8bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥710m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2021-10-01 → 2021-12-31¥227m
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentsegment profit2021-04-01 → 2021-12-31¥3.8bn
jpcrp040300-q3r_E05425-000Evidence Solutionreportable segmentsegment profit2021-10-01 → 2021-12-31¥1.8bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue2021-04-01 → 2021-12-31¥64.7bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue2021-10-01 → 2021-12-31¥26.3bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue external2021-04-01 → 2021-12-31¥62.7bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue external2021-10-01 → 2021-12-31¥25.6bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥2.0bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentrevenue intersegment2021-10-01 → 2021-12-31¥674m
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentsegment profit2021-04-01 → 2021-12-31¥30.8bn
jpcrp040300-q3r_E05425-000Medical Platformreportable segmentsegment profit2021-10-01 → 2021-12-31¥14.1bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue2021-04-01 → 2021-12-31¥37.9bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue2021-10-01 → 2021-12-31¥13.5bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue external2021-04-01 → 2021-12-31¥37.8bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue external2021-10-01 → 2021-12-31¥13.5bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥17m
jpcrp040300-q3r_E05425-000Overseasreportable segmentrevenue intersegment2021-10-01 → 2021-12-31¥5m
jpcrp040300-q3r_E05425-000Overseasreportable segmentsegment profit2021-04-01 → 2021-12-31¥41.5bn
jpcrp040300-q3r_E05425-000Overseasreportable segmentsegment profit2021-10-01 → 2021-12-31¥3.4bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue2021-04-01 → 2021-12-31¥25.7bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue2021-10-01 → 2021-12-31¥8.2bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue external2021-04-01 → 2021-12-31¥25.2bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue external2021-10-01 → 2021-12-31¥8.0bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥438m
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentrevenue intersegment2021-10-01 → 2021-12-31¥200m
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentsegment profit2021-04-01 → 2021-12-31¥4.6bn
jpcrp040300-q3r_E05425-000Site Solutionreportable segmentsegment profit2021-10-01 → 2021-12-31¥2.0bn
—segment totalrevenue2021-04-01 → 2021-12-31¥155.4bn
—segment totalrevenue2021-10-01 → 2021-12-31¥56.8bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥151.8bn
—segment totalrevenue external2021-10-01 → 2021-12-31¥55.6bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥3.6bn
—segment totalrevenue intersegment2021-10-01 → 2021-12-31¥1.2bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥84.7bn
—segment totalsegment profit2021-10-01 → 2021-12-31¥21.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 789
ItemContextValueUnit
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember678951500
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember678951800
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant678951500
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant678951800
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember45100
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember678771600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember6787716
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember122900
Number of shares issued shares voting rightsCurrentQuarterInstant678939600
Number of voting rights issued shares voting rightsCurrentQuarterInstant6787716
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member45100
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member45100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0001
Number of shares held in own name treasury shares etcCurrentQuarterInstant45100
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant45100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0001
Cash and cash equivalents IFRSPrior1YearInstant104253000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant109757000000JPY
Trade and other receivables ca IFRSPrior1YearInstant50879000000JPY
Trade and other receivables ca IFRSCurrentQuarterInstant55808000000JPY
Other financial assets ca IFRSPrior1YearInstant36963000000JPY
Other financial assets ca IFRSCurrentQuarterInstant24955000000JPY
Other current assets ca IFRSPrior1YearInstant6779000000JPY
Other current assets ca IFRSCurrentQuarterInstant6929000000JPY
Current assets IFRSPrior1YearInstant198874000000JPY
Current assets IFRSCurrentQuarterInstant197450000000JPY
Property plant and equipment IFRSPrior1YearInstant12540000000JPY
Property plant and equipment IFRSCurrentQuarterInstant16021000000JPY
Goodwill IFRSPrior1YearInstant57821000000JPY
Goodwill IFRSCurrentQuarterInstant68175000000JPY
Intangible assets IFRSPrior1YearInstant25081000000JPY
Intangible assets IFRSCurrentQuarterInstant36674000000JPY
Investments accounted for using equity method IFRSPrior1YearInstant37152000000JPY
Investments accounted for using equity method IFRSCurrentQuarterInstant44848000000JPY
Financial assets measured at fair value nca IFRSPrior1YearInstant7596000000JPY
Financial assets measured at fair value nca IFRSCurrentQuarterInstant10768000000JPY
Other financial assets nca IFRSPrior1YearInstant2745000000JPY
Other financial assets nca IFRSCurrentQuarterInstant2490000000JPY
Deferred tax assets IFRSPrior1YearInstant2137000000JPY
Deferred tax assets IFRSCurrentQuarterInstant2242000000JPY
Other non current assets nca IFRSPrior1YearInstant2034000000JPY
Other non current assets nca IFRSCurrentQuarterInstant2058000000JPY
Non current assets IFRSPrior1YearInstant147107000000JPY
Non current assets IFRSCurrentQuarterInstant183276000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass